Motor dysfunction produced by tacrine administration in rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 4, 1997, Pages 851-858

  Carriero, D L ^a   Outslay, G ^a   Mayorga, A J ^a   Aberman, J ^a   Gianutsos, G ^a   Salamone, J D ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Alzheimer's disease; Cognex; Locomotion; Motor; Operant; Parkinson's disease; Tremor

Indexed keywords

CHOLINESTERASE INHIBITOR; TACRINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; JAW MOVEMENT; LOCOMOTION; MALE; MOTOR DYSFUNCTION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT;

EID: 0031406973     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)98986-3     Document Type: Article

References (54)

1. Adams R. D., Victor M. Tremors, myoclonus, spasms and tics. Principles of neurology. 1981;69-77 McGraw-Hill, New York.
2. Aquilonius S. M. Cholinergic mechanisms in the CNS related to Parkinson's disease. Parkinson's Disease - Current progress, problems and management:1980;Elsevier, North Holland. 17-27.
3. Baskin P., Salamone J. D. Vacuous jaw movements in rats induced by acute reserpine administration. Interactions with different doses of apomorphine Pharmacol. Biochem. Behav. 46:1993;793-797.
4. Baskin P., Gianutsos G., Salamone J. D. Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding. Pharmacol. Biochem. Behav. 49:1994;437-442.
5. Bruning J. L., Kintz B. L. Computational handbook of statistics. 1987;Scott, Foresman and Co, Glenview, IL.
6. Chesler E. J., Salamone J. D. Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements. Pharmacol. Biochem. Behav. 54:1996;619-624.
7. Cousins M. S., Carriero D. L., Salamone J. D. Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine. Effects of antiparkinsonian drugs Eur. J. Pharmacol. 322:1997;137-145.
8. Cousins M. S., Sokolowski J. D., Salamone J. D. Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacol. Biochem. Behav. 46:1993;943-951.
9. Cousins M. S., Salamone J. D. Involvement of ventrolateral striatal dopamine in movement initiation and execution. A microdialysis and behavioral investigation Neuroscience. 70:1996;849-859.
10. Cousins M. S., Salamone J. D. Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions. Behavioral and pharmacological characterization Brain Res. 732:1996;186-194.
11. Cousins M. S., Wei W., Salamone J. D. Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure. Effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs Psychopharmacology (Berlin). 116:1994;529-537.
12. DeNoble V. J., DeNoble K. F., Spencer K. R., Johnson L. C., Cook L., Myers M. J., Scribner R. M. Comparison of DuP 996, with physostigmine, THA and 3,4-DAP on hypoxia-induced amnesia in rats. Pharmacol. Biochem. Behav. 36:1990;957-961.
13. Duvoisin R. C. Cholinergic-anticholinergic antagonism in parkinsonism. Arch. Neurol. 17:1967;124-136.
14. Eguchi J., Yuasa T., Egawa M., Tobe A. Effects of a novel compound MCI-225 on impaired learning and memory in rats. Pharmacol. Biochem. Behav. 48:1994;345-349.
15. Faustman W. O., Fowler S. C. Use of operant response duration to distinguish between the effects of haloperidol and nonreward. Pharmacol. Biochem. Behav. 15:1981;327-329.
16. Findley L. J., Gresty M. A. Tremor and rythmical involuntary movements in Parkinson's disease. Findley L. H., Capildeo R. Movement disorders. Tremor:1984;295-304 Oxford University Press, New York.
17. Finn M., Jassen A., Baskin P. Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions. Pharmacol. Biochem. Behav. 57:1997;243-249.
18. 2 (raclopride) antagonists Psychopharmacology (Berlin). 115:1994;24-30.
19. Gianutsos G. Altered pilocarpine- or chlorpromazine-induced catalepsy after long-term treatment with cholinergic drugs. Psychopharmacology (Berlin). 66:1979;121-125.
20. Hagan J. J., Jansen J. H. M., Broekkamp C. L. E. Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics. Psychopharmacology (Berlin). 98:1989;347-356.
21. Harbaugh R. E., Roberts D. W., Coombs D. W., Saunders R. L., Reeder T. M. Preliminary report. Intracranial cholinergic drug infusion in patients with Alzheimer's disease Neurosurgery. 15:1984;514-518.
22. Hunker C. J., Abbs J. H. Uniform frequency of parkinsonian resting tremor in the lips, jaw, tongue and index finger. Mov. Disord. 5:1990;71-77.
23. Hunter A. J., Murray T. K., Jones J. A., Cross A. J., Green A. R. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Br. J. Pharmacol. 98:1989;79-86.
24. Janssen P. A., Niemegeers C. J. F., Schellekens K. H. L. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? Arzneimittelforschung. 15:1965;104-117.
25. Jicha G., Salamone J. D. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletions. Possible model of parkinsonian symptoms J. Neurosci. 11:1991;3822-3829.
26. Kelley A. E., Bakshi V. P., Delfs J. M., Lang C. G. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats. Pharmacological and regional specificity Psychopharmacology (Berlin). 99:1989;542-549.
27. Keppel G Design and Analysis. A researchers handbook:1982;Prentice-Hall, Englewood Cliffs, NJ.
28. Keseberg U., Schmidt W. J. Tetrahydroaminoacridine attenuates dizoclipine-induced behavioural changes. Behav. Brain Res. 26:1993;113-118.
29. Klemm W. R. Evidence for a cholinergic role in haloperidol-induced catalepsy. Psychopharmacology (Berlin). 85:1985;139-142.
30. Koob G. F., Riley S. J., Smith S. C., Robbins T. W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat. J. Comp. Physiol. Psychol. 92:1978;917-927.
31. Marsden C. D., Tarsy D., Baldessarini R. J. Spontaneous and drug-induced movement disorders in psychotic patients. Bendon D. F., Blumer D. Psychiatric aspects of neurological disease. 1975;219-266 Grune and Stratten, New York.
32. Mayorga A. J., Carriero D. L., Cousins M. S., Gianutsos G., Salamone J. D. Tremulous jaw movements produced by acute tacrine administration. Possible relation to parkinsonian side effects Pharmacol. Biochem. Behav. 56:1997;273-279.
33. McEvoy J. P. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J. Clin. Psychopharmacol. 3:1983;288-301.
34. Nielsen J. A., Mena E. E., Williams I. H., Nocerini M. R., Liston D. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with neurochemical and behavioral changes. Eur. J. Pharmacol. 173:1989;53-64.
35. Noring U., Povlesen U. J., Casey D. E., Gerlach J. Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonism. Psychopharmacology (Berlin). 84:1984;569-571.
36. Ott B. R., Lannon M. C. Exacerbation of Parkinsonism by tacrine. Clin. Neuropharmacol. 15:1992;322-325.
37. Physicians desk reference. Montville, NJ: Medical Economics; 1995.
38. Porter J. H., Villanueva H. F. Assessment of pimozides motor and hedonic effects on operant behavior in rats. Pharmacol. Biochem. Behav. 31:1989;779-786.
39. Rupniak N. M. J., Jenner P., Marsden C. D. Cholinergic modulation of perioral behavior induced by chronic neuroleptic administration to rats. Psychopharmacology (Berlin). 79:1983;226-230.
40. Rupniak N. M. J., Jenner P., Marsden C. D. Pharmacological characterization of spontaneous or drug-induced purposeless chewing movements in rats. Psychopharmacology (Berlin). 85:1985;71-79.
41. Rupniak N. M. J., Jenner P., Marsden C. D. Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berlin). 88:1986;403-419.
42. Salamone J. D., Baskin P. B. Vacuous jaw movements induced by reserpine and low-dose apomorphine. Possible model of parkinsonian tremor Pharmacol. Biochem. Behav. 53:1996;179-183.
43. Salamone J. D., Kurth P., McCullough L. D., Sokolowski J. D. The effects of nucleus accumbens dopamine depletions on continuously reinforced operant responding. Contrasts with the effects of extinction Pharmacol. Biochem. Behav. 50:1995;437-443.
44. Salamone J. D., Lalies M. D., Channell S. L., Iversen S. D. Behavioral and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology (Berlin). 88:1986;467-471.
45. Salamone J. D., Johnson C. J., McCullough L. D., Steinpreis R. E. Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacology (Berlin). 102:1990;529-534.
46. Salamone J. D., Kurth P. A., McCullough L. D., Sokolowski J. D., Cousins M. S. The role of brain dopamine in response initiation. Effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding Brain Res. 628:1993;218-226.
47. See R., Chapman M. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats. Pharmacol. Biochem. Behav. 39:1991;49-54.
48. Souskova M., Benesova O., Roth Z. The effect of chlorpromazine, phenmetrazine, imipramine and physostigmine on the exploratory and conditioned avoidance reaction in rats with different excitability of the central nervous system. Psychopharmacology (Berlin). 5:1964;447-456.
49. Steinpreis R. E., Baskin P. P., Salamone J. D. Vacuous jaw movements induced by subchronic administration of haloperidol. Interactions with scopolamine Psychopharmacology (Berlin). 111:1993;99-105.
50. Stewart B. R., Jenner P., Marsden C. D. The pharmacological characterization of pilocarpine-induced chewing in the rat. Psychopharmacology (Berlin). 97:1988;228-234.
51. Stewart B. R., Jenner P., Marsden C. D. Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour. Psychopharmacology (Berlin). 97:1989;228-234.
52. Tarsy D. Neuroleptic-induced extrapyramidal reactions. Classification, description and diagnosis Clin. Neuropharmacol. 6:1983;s9-s26.
53. Waddington J. L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration. Phenomenology, pathophysiology and putative relationship to tardive dyskinesia Psychopharmacology (Berlin). 101:1990;431-447.
54. Weiss K. J., Ciraulo D. A., Shader R. I. Physostigmine test in the rabbit syndrome and tardive dyskinesia. Am. J. Psychiatry. 137:1980;627-628.